Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-04 | New | $2,500,000 | $2,500,000 | Equity Only | 06b | SEC link |
| 2024-10-11 | New | $2,500,638 | $2,500,638 | Equity Only | 06b | SEC link |
| 2022-07-13 | New | $2,499,945 | $2,499,945 | Equity Only | 06b | SEC link |
| 2021-04-20 | New | $4,999,999 | $4,999,999 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Robert Bloder | Director |
| Colin Foster | Director |
| James Gale | Director |
| Jingjun Huang | Director, Executive |
| Shoufeng Li | Director |
| Theron Odlaug | Director |